Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

BIOSAND ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading... Loading... Loading... Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.7% 2.7%   Bankruptcy risk   7.4% 17.7% 11.7% 6.5% 8.5% 10.4% 16.7% 16.7%   Credit score (0-100)   34 9 20 35 28 22 10 10   Credit rating   BB B BB BBB BB BB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 -0.0 -0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   251 117 82 83 45 69 69 69   Gross profit   55.9 -52.9 -26.1 22.3 -14.8 -17.2 0.0 0.0   EBITDA   50.4 -52.9 -26.1 22.3 -14.8 -17.2 0.0 0.0   EBIT   50.4 -57.3 -26.1 16.8 -20.3 -22.7 0.0 0.0   Pre-tax profit (PTP)   50.9 -57.2 -27.1 15.9 -20.8 -22.9 0.0 0.0   Net earnings   39.6 -57.2 -27.1 15.9 -20.8 -22.9 0.0 0.0   Pre-tax profit without non-rec. items   50.9 -57.2 -27.1 15.9 -20.8 -22.9 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 13.2 33.0 27.5 22.0 16.5 0.0 0.0   Shareholders equity total   119 72.8 45.7 60.6 39.7 16.8 -22.9 -22.9   Interest-bearing liabilities   0.0 0.0 0.0 0.0 0.0 0.0 22.9 22.9   Balance sheet total (assets)   228 149 118 150 107 85.3 0.0 0.0   Net Debt   -147 -114 -79.5 -118 -76.9 -65.0 22.9 22.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   251 117 82 83 45 69 69 69   Net sales growth   8.6% -53.4% -29.8% 0.7% -45.7% 54.1% 0.0% 0.0%   Gross profit   55.9 -52.9 -26.1 22.3 -14.8 -17.2 0.0 0.0   Gross profit growth   237.4% 0.0% 50.6% 0.0% 0.0% -16.5% 0.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   228 149 118 150 107 85 0 0   Balance sheet change%   8.9% -34.6% -20.8% 26.5% -28.3% -20.5% -100.0% 0.0%   Added value   50.4 -52.9 -26.1 22.3 -14.8 -17.2 0.0 0.0   Added value %   20.1% -45.2% -31.8% 26.9% -33.0% -25.0% 0.0% 0.0%   Investments   -5 9 20 -11 -11 -11 -17 0   Net sales trend   1.0 -1.0 -2.0 1.0 -1.0 1.0 0.0 0.0   EBIT trend   3.0 -1.0 -2.0 1.0 -1.0 -2.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   20.1% -45.2% -31.8% 26.9% -33.0% -25.0% 0.0% 0.0%   EBIT %   20.1% -49.0% -31.8% 20.3% -45.2% -32.9% 0.0% 0.0%   EBIT to gross profit (%)   90.2% 108.3% 100.0% 75.3% 137.2% 131.9% 0.0% 0.0%   Net Earnings %   15.8% -48.9% -33.0% 19.2% -46.5% -33.2% 0.0% 0.0%   Profit before depreciation and extraordinary items %   15.8% -45.2% -33.0% 25.9% -34.2% -25.2% 0.0% 0.0%   Pre tax profit less extraordinaries %   20.3% -48.9% -33.0% 19.2% -46.5% -33.2% 0.0% 0.0%   ROA %   23.3% -30.3% -19.5% 12.5% -15.8% -23.6% 0.0% 0.0%   ROI %   51.0% -59.6% -44.1% 31.5% -40.5% -80.4% 0.0% 0.0%   ROE %   39.6% -59.6% -45.7% 29.9% -41.5% -81.1% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   52.2% 48.8% 38.7% 40.5% 37.1% 19.7% -100.0% -100.0%   Relative indebtedness %   43.5% 65.5% 88.4% 107.7% 150.5% 99.1% 33.2% 33.2%   Relative net indebtedness %   -15.2% -31.9% -8.5% -35.5% -20.9% 5.0% 33.2% 33.2%   Net int. bear. debt to EBITDA, %   -291.9% 215.2% 304.6% -531.8% 519.7% 377.2% 0.0% 0.0%   Gearing %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% -100.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   2.3 1.8 1.2 1.4 1.3 1.0 0.0 0.0   Current Ratio   2.3 1.8 1.2 1.4 1.3 1.0 0.0 0.0   Cash and cash equivalent   147.2 113.8 79.5 118.3 76.9 65.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   115.1 63.5 0.0 0.0 37.4 0.0 0.0 0.0   Trade creditors turnover (days)   11.6 4.9 6.7 5.6 66.4 5.3 0.0 0.0   Current assets / Net sales %   91.0% 116.4% 103.9% 147.7% 190.1% 99.5% 0.0% 0.0%   Net working capital   130.3 59.6 12.7 33.1 17.7 0.3 -11.5 -11.5   Net working capital %   52.0% 51.0% 15.5% 40.0% 39.6% 0.4% -16.6% -16.6%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0